Topical Corticosteroids — Complete Guide
Topical corticosteroids (TCS) are the most widely used drug class in dermatology. Used correctly: safe, fast, effective. Used inappropriately: skin atrophy, telangiectasia, perioral dermatitis. The key is matching potency to body site, disease, and duration.
7-Class Potency Hierarchy (US Convention)
| Class | Strength | Examples | Typical use |
|---|---|---|---|
| I (super-potent) | Strongest | Clobetasol propionate 0.05%, Diflorasone 0.05%, Halobetasol 0.05% | Palms / soles / chronic plaques; ≤ 2 weeks |
| II (potent) | Strong | Mometasone 0.1% oint, Fluocinonide 0.05%, Betamethasone diprop 0.05% | Trunk / extremities thick plaques |
| III | Mid-strong | Triamcinolone 0.5%, Fluticasone 0.005% | Trunk, limbs |
| IV | Mid | Triamcinolone 0.1%, Mometasone 0.1% cream | Daily-use trunk / limbs |
| V | Mid-mild | Hydrocortisone valerate 0.2%, Fluticasone 0.05% | Pediatric, face / fold short-course |
| VI | Mild | Desonide 0.05%, Hydrocortisone 1-2.5% | Face / eyelids / genitals / infants |
| VII (mildest) | OTC | Hydrocortisone 0.5-1% (OTC) | Mild irritation, kids face |
Match Potency to Site
| Body site | Recommended class | Notes |
|---|---|---|
| Eyelids / face / genitals / folds | VI-VII (mild only) | Higher penetration; atrophy risk; max 2-4 wks; consider TCI |
| Trunk / extremities | III-IV | Standard daily use |
| Palms / soles / scalp / chronic thick plaques | I-II (potent / super-potent) | 2 weeks then taper to weekend therapy |
| Pediatric | One class milder than adult equivalent | Higher BSA / mass ratio absorbs more |
Finger-Tip Unit (FTU) Dosing
1 FTU = strip of cream from a 5-mm tube nozzle from fingertip to first crease ≈ 0.5 g; covers ~ 2 palms (300 cm²).
| Body region | FTU per application |
|---|---|
| Face + neck | 2.5 FTU |
| One arm + hand | 3 FTU |
| One hand (front + back) | 1 FTU |
| One leg + foot | 6 FTU |
| Trunk front | 7 FTU |
| Trunk back + buttocks | 7 FTU |
Treatment Strategy
- Acute flare: BID × 7-14 days, taper to once daily, then weekend-only ("proactive therapy")
- Maintenance / proactive: twice-weekly to high-risk sites prevents flares (atopic dermatitis evidence)
- Combine with moisturizer: not in same hand-rub motion; layer separately (steroid first, wait 5 min, then moisturizer)
- Don't use on infections alone (tinea, herpes, impetigo) — masks but worsens infection
- Wean off, don't stop abruptly after long use to prevent rebound
Side Effects & Precautions
- Local: skin atrophy, striae, telangiectasia, easy bruising, hypopigmentation, hypertrichosis, perioral dermatitis, steroid acne, steroid rosacea
- Systemic (rare; large area, high potency, long duration): HPA axis suppression, growth retardation in kids, glaucoma if periocular
- Tachyphylaxis: receptor downregulation with continuous use — solved by intermittent use
Topical Steroid Phobia
Patient fear of "addiction" or "withdrawal" leads to undertreatment. True "topical steroid withdrawal" is rare and only after prolonged inappropriate use. Used correctly with class-matched potency and proactive maintenance, TCS are safe long-term. Educate patients with the "weekend therapy" concept: 2× weekly maintenance prevents flares without continuous daily use.
Steroid-Sparing Alternatives
- Topical Calcineurin Inhibitors (TCI): Tacrolimus 0.03% / 0.1% oint, Pimecrolimus 1% cream — no atrophy, ideal for face / eyelids / folds
- Topical PDE-4 inhibitor: Crisaborole 2% — for mild-moderate AD ≥ 2 yo
- Topical JAK inhibitor: Ruxolitinib 1.5% cream — moderate AD ≥ 12 yo, vitiligo
Summary
Used correctly, topical steroids are the cornerstone of inflammatory skin disease treatment. The keys: right potency for the site, time-limited acute treatment, proactive weekend maintenance, and combining with moisturizer + steroid-sparing agents (TCI, JAK) for long-term care. Don't fear TCS — fear inappropriate use.